Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and α-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension
M. Giordano, M. Matsuda, L. Sanders, M. L. Canessa, R. A. DeFronzo
Profundice en los temas de investigación de 'Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and α-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension'. En conjunto forman una huella única.